IRIS
ADORNATO, ILENIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 479
NA - Nord America 370
AS - Asia 55
Totale 904
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 369
IE - Irlanda 143
PL - Polonia 103
SE - Svezia 101
IT - Italia 88
CN - Cina 39
DE - Germania 11
FI - Finlandia 7
NL - Olanda 7
SG - Singapore 7
FR - Francia 6
BE - Belgio 5
IN - India 5
RU - Federazione Russa 3
CZ - Repubblica Ceca 2
GB - Regno Unito 2
VN - Vietnam 2
AT - Austria 1
CA - Canada 1
PK - Pakistan 1
TR - Turchia 1
Totale 904
Salva come PNG Salva come JPEG
Città #
Dublin 143
Chandler 116
Warsaw 102
Nyköping 81
Messina 30
Ashburn 27
Dearborn 25
Princeton 21
Medford 15
Beijing 14
Ann Arbor 13
Des Moines 11
San Mateo 9
Jacksonville 8
Munich 7
Haikou 6
Brussels 5
Francofonte 5
Rome 5
Amsterdam 4
Cagliari 4
Cambridge 4
Boardman 3
Den Haag 3
Falls Church 3
Florence 3
Fontaniva 3
Guangzhou 3
Helsinki 3
Pune 3
Seattle 3
Singapore 3
Wilmington 3
Brno 2
Clearwater 2
Dong Ket 2
Fuzhou 2
Hyderabad 2
Malfa 2
Nanjing 2
Ningbo 2
Palermo 2
Riva 2
Shenyang 2
Taizhou 2
Washington 2
Aci Sant'antonio 1
Augusta 1
Brunico 1
Büdelsdorf 1
Changsha 1
Chengdu 1
Cupertino 1
Frankfurt am Main 1
Houston 1
Jinan 1
Lanzhou 1
Lappeenranta 1
Los Angeles 1
Montpellier 1
Montréal 1
Redwood City 1
Saint-denis 1
Saratov 1
Siracusa 1
Southend 1
Stamford 1
Taiyuan 1
Tianjin 1
Vienna 1
Totale 738
Salva come PNG Salva come JPEG
Nome #
Progettazione, sintesi e valutazione di nuove molecole attive come inibitori di enzimi coinvolti nello sviluppo del diabete mellito e delle sue complicazioni 177
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 75
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 62
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 61
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 51
null 50
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease 50
Evaluation of 4-(4-Fluorobenzyl)piperazin-1-yl]-Based Compounds as Competitive Tyrosinase Inhibitors Endowed with Antimelanogenic Effects 50
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules 48
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 46
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 44
INVESTIGATION ON PYRIDINYL-1,2,4-TRIAZOLE-BASED COMPOUNDS AS -SYN AGGREGATION INHIBITORS FOR TREATING PARKINSON’S DISEASE 42
Searching for alpha-syn inhibitors to fight Parkinson’s disease 41
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B 40
EVALUATION OF 4-THIAZOLIDINONE DERIVATIVES AS ALPHA-AMYLASE INHIBITORS 33
Synthesis and biochemical evaluation of 5-(pyridin-4-yl)-4H-1,2,4-triazol-4-amine-based inhibitors of tyrosinase from Agaricus bisporus 32
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 25
null 13
null 12
Totale 952
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.581
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020121 1 2 4 2 9 28 21 15 6 17 9 7
2020/202184 9 6 12 2 12 3 5 2 20 4 5 4
2021/2022146 0 19 1 16 15 10 8 2 2 14 6 53
2022/2023405 27 69 23 30 13 41 21 7 161 0 8 5
2023/2024100 7 14 6 22 6 12 0 6 2 3 1 21
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 952